{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T10:31:34Z","timestamp":1688985094008},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2016,9,15]],"date-time":"2016-09-15T00:00:00Z","timestamp":1473897600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s00115-016-0210-1","type":"journal-article","created":{"date-parts":[[2016,9,15]],"date-time":"2016-09-15T12:56:20Z","timestamp":1473944180000},"page":"1115-1126","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pharmakologische Epilepsiethe\ufeffrapie bei Kinderwunsch und in der Schwangerschaft"],"prefix":"10.1007","volume":"87","author":[{"given":"B.","family":"M\u00fcffelmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. G.","family":"Bien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,9,15]]},"reference":[{"key":"210_CR1","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s00115-008-2632-x","volume":"80","author":"TW May","year":"2009","unstructured":"May TW, Pfafflin M, Coban I et\u00a0al (2009) Fears, knowledge, and need of counseling for women with epilepsy. Results of an outpatient study. Nervenarzt 80:174\u2013183","journal-title":"Nervenarzt"},{"key":"210_CR2","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1136\/jnnp-2013-306318","volume":"85","author":"E Campbell","year":"2014","unstructured":"Campbell E, Kennedy F, Russell A et\u00a0al (2014) Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy Registers. J\u00a0Neurol Neurosurg Psychiatry 85:1029\u20131034","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"210_CR3","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1212\/WNL.0b013e3182574f39","volume":"78","author":"S Hernandez-Diaz","year":"2012","unstructured":"Hernandez-Diaz S, Smith CR, Shen A et al (2012) Comparative safety of antiepileptic drugs during pregnancy. Neurology 78:1692\u20131699","journal-title":"Neurology"},{"key":"210_CR4","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1474-4422(11)70107-7","volume":"10","author":"T Tomson","year":"2011","unstructured":"Tomson T, Battino D, Bonizzoni E et al (2011) Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol 10:609\u2013617","journal-title":"Lancet Neurol"},{"key":"210_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2008.04.022","volume":"81","author":"K Meador","year":"2008","unstructured":"Meador K, Reynolds MW, Crean S et al (2008) Pregnancy outcomes in women with epilepsy: a systematic review and meta-analysis of published pregnancy registries and cohorts. Epilepsy Res 81:1\u201313","journal-title":"Epilepsy Res"},{"key":"210_CR6","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1212\/01.wnl.0000318293.28278.33","volume":"71","author":"S Hunt","year":"2008","unstructured":"Hunt S, Russell A, Smithson WH et\u00a0al (2008) Topiramate in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register. Neurology 71:272\u2013276","journal-title":"Neurology"},{"key":"210_CR7","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1212\/WNL.0b013e31827f0874","volume":"80","author":"E Mawhinney","year":"2013","unstructured":"Mawhinney E, Craig J, Morrow J et\u00a0al (2013) Levetiracetam in pregnancy: results from the UK and Ireland epilepsy and pregnancy registers. Neurology 80:400\u2013405","journal-title":"Neurology"},{"key":"210_CR8","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.seizure.2015.02.019","volume":"28","author":"T Tomson","year":"2015","unstructured":"Tomson T, Xue H, Battino D (2015) Major congenital malformations in children of women with epilepsy. Seizure 28:46\u201350","journal-title":"Seizure"},{"key":"210_CR9","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00415-013-7239-x","volume":"261","author":"G Veiby","year":"2014","unstructured":"Veiby G, Daltveit AK, Engelsen BA et\u00a0al (2014) Fetal growth restriction and birth defects with newer and older antiepileptic drugs during pregnancy. J\u00a0Neurol 261:579\u2013588","journal-title":"J Neurol"},{"key":"210_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/s1474-4422(15)00314-2","author":"T Tomson","year":"2015","unstructured":"Tomson T, Battino D, Perucca E (2015) Valproic acid after five decades of use in epilepsy: time to reconsider the indications of a time-honoured drug. Lancet Neurol. doi: 10.1016\/s1474-4422(15)00314-2","journal-title":"Lancet Neurol"},{"key":"210_CR11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.reprotox.2015.03.003","volume":"53","author":"AM Alsaad","year":"2015","unstructured":"Alsaad AM, Chaudhry SA, Koren G (2015) First trimester exposure to topiramate and the risk of oral clefts in the offspring: A systematic review and meta-analysis. Reprod Toxicol 53:45\u201350","journal-title":"Reprod Toxicol"},{"key":"210_CR12","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s00415-012-6662-8","volume":"260","author":"M Rauchenzauner","year":"2013","unstructured":"Rauchenzauner M, Ehrensberger M, Prieschl M et al (2013) Generalized tonic-clonic seizures and antiepileptic drugs during pregnanc y \u2013 a matter of importance for the baby? J Neurol 260:484\u2013488","journal-title":"J Neurol"},{"key":"210_CR13","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1111\/epi.12621","volume":"55","author":"S Edey","year":"2014","unstructured":"Edey S, Moran N, Nashef L (2014) SUDEP and epilepsy-related mortality in pregnancy. Epilepsia 55:e72\u2013e74","journal-title":"Epilepsia"},{"key":"210_CR14","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S1474-4422(13)70214-X","volume":"12","author":"P Ryvlin","year":"2013","unstructured":"Ryvlin P, Nashef L, Lhatoo SD et\u00a0al (2013) Incidence and mechanisms of cardiorespiratory arrests in epilepsy monitoring units (MORTEMUS): a retrospective study. Lancet Neurol 12:966\u2013977","journal-title":"Lancet Neurol"},{"key":"210_CR15","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1212\/WNL.0000000000001772","volume":"85","author":"T Tomson","year":"2015","unstructured":"Tomson T, Battino D, Bonizzoni E et al (2015) Dose-dependent teratogenicity of valproate in mono- and polytherapy: an observational study. Neurology 85:866\u2013872","journal-title":"Neurology"},{"key":"210_CR16","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S1474-4422(12)70323-X","volume":"12","author":"KJ Meador","year":"2013","unstructured":"Meador KJ, Baker GA, Browning N et\u00a0al (2013) Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study. Lancet Neurol 12:244\u2013252","journal-title":"Lancet Neurol"},{"key":"210_CR17","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1212\/WNL.0000000000001182","volume":"84","author":"GA Baker","year":"2015","unstructured":"Baker GA, Bromley RL, Briggs M et\u00a0al (2015) IQ at 6 years after in utero exposure to antiepileptic drugs: a controlled cohort study. Neurology 84:382\u2013390","journal-title":"Neurology"},{"key":"210_CR18","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1001\/jama.2013.2270","volume":"309","author":"J Christensen","year":"2013","unstructured":"Christensen J, Gronborg TK, Sorensen MJ et\u00a0al (2013) Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA 309:1696\u20131703","journal-title":"JAMA"},{"key":"210_CR19","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/epi.13007","volume":"56","author":"AG Wood","year":"2015","unstructured":"Wood AG, Nadebaum C, Anderson V et\u00a0al (2015) Prospective assessment of autism traits in children exposed to antiepileptic drugs during pregnancy. Epilepsia 56:1047\u20131055","journal-title":"Epilepsia"},{"key":"210_CR20","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.yebeh.2013.08.001","volume":"29","author":"MJ Cohen","year":"2013","unstructured":"Cohen MJ, Meador KJ, Browning N et\u00a0al (2013) Fetal antiepileptic drug exposure: Adaptive and emotional\/behavioral functioning at age 6years. Epilepsy Behav 29:308\u2013315","journal-title":"Epilepsy Behav"},{"key":"210_CR21","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/epi.13043","volume":"56","author":"S McCrary Van","year":"2015","unstructured":"Van McCrary S (2015) Commentary: Revised recommendation from CMDh on use of valproate in women is ethically incomplete and neglects the interests of women. Epilepsia 56:1020\u20131022","journal-title":"Epilepsia"},{"key":"210_CR22","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/epi.13021","volume":"56","author":"T Tomson","year":"2015","unstructured":"Tomson T, Marson A, Boon P et\u00a0al (2015) Valproate in the treatment of epilepsy in girls and women of childbearing potential. Epilepsia 56:1006\u20131019","journal-title":"Epilepsia"},{"key":"210_CR23","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1056\/NEJM199212243272602","volume":"327","author":"AE Czeizel","year":"1992","unstructured":"Czeizel AE, Dudas I (1992) Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 327:1832\u20131835","journal-title":"N Engl J Med"},{"key":"210_CR24","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/ana.22229","volume":"69","author":"M Linnebank","year":"2011","unstructured":"Linnebank M, Moskau S, Semmler A et\u00a0al (2011) Antiepileptic drugs interact with folate and vitamin B12 serum levels. Ann Neurol 69:352\u2013359","journal-title":"Ann Neurol"},{"key":"210_CR25","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/S1701-2163(16)32685-8","volume":"29","author":"RD Wilson","year":"2007","unstructured":"Wilson RD, Johnson JA, Wyatt P et al (2007) Pre-conceptional vitamin\/folic acid supplementation 2007: the use of folic acid in combination with a multivitamin supplement for the prevention of neural tube defects and other congenital anomalies. J Obstet Gynaecol Can 29:1003\u20131026","journal-title":"J Obstet Gynaecol Can"},{"key":"210_CR26","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1111\/j.1528-1167.2009.02130.x","volume":"50","author":"CL Harden","year":"2009","unstructured":"Harden CL, Pennell PB, Koppel BS et al (2009) Management issues for women with epilepsy \u2013 focus on pregnancy (an evidence-based review): III. Vitamin\u00a0K, folic acid, blood levels, and breast-feeding: Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Epilepsia 50:1247\u20131255","journal-title":"Epilepsia"},{"key":"210_CR27","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.seizure.2015.02.021","volume":"28","author":"L Sveberg","year":"2015","unstructured":"Sveberg L, Vik K, Henriksen T et\u00a0al (2015) Women with epilepsy and post partum bleeding \u2013 Is there a role for vitamin K supplementation? Seizure 28:85\u201387","journal-title":"Seizure"},{"key":"210_CR28","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1212\/01.wnl.0000195888.51845.80","volume":"66","author":"The EURAP Study Group","year":"2006","unstructured":"The EURAP Study Group (2006) Seizure control and treatment in pregnancy: observations from the EURAP epilepsy pregnancy registry. Neurology 66:354\u2013360","journal-title":"Neurology"},{"key":"210_CR29","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/j.1528-1167.2009.02129.x","volume":"50","author":"CL Harden","year":"2009","unstructured":"Harden CL, Meador KJ, Pennell PB et al (2009) Management issues for women with epilepsy-Focus on pregnancy (an evidence-based review): II. Teratogenesis and perinatal outcomes: Report of the Quality Standards Subcommittee and Therapeutics and Technology Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Epilepsia 50:1237\u20131246","journal-title":"Epilepsia"},{"key":"210_CR30","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.seizure.2014.08.008","volume":"24","author":"FJ Vajda","year":"2015","unstructured":"Vajda FJ, O\u2019brien TJ, Graham J et\u00a0al (2015) The outcomes of pregnancy in women with untreated epilepsy. Seizure 24:77\u201381","journal-title":"Seizure"},{"key":"210_CR31","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/epi.12711","volume":"55","author":"FJ Vajda","year":"2014","unstructured":"Vajda FJ, O\u2019brien T, Lander C et\u00a0al (2014) The efficacy of the newer antiepileptic drugs in controlling seizures in pregnancy. Epilepsia 55:1229\u20131234","journal-title":"Epilepsia"},{"key":"210_CR32","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1111\/epi.12302","volume":"54","author":"D Battino","year":"2013","unstructured":"Battino D, Tomson T, Bonizzoni E et\u00a0al (2013) Seizure control and treatment changes in pregnancy: observations from the EURAP epilepsy pregnancy registry. Epilepsia 54:1621\u20131627","journal-title":"Epilepsia"},{"key":"210_CR33","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/FTD.0b013e318178e2a9","volume":"30","author":"V Franco","year":"2008","unstructured":"Franco V, Mazzucchelli I, Gatti G et\u00a0al (2008) Changes in lamotrigine pharmacokinetics during pregnancy and the puerperium. Ther Drug Monit 30:544\u2013547","journal-title":"Ther Drug Monit"},{"key":"210_CR34","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1212\/01.wnl.0000289511.20864.2a","volume":"70","author":"PB Pennell","year":"2008","unstructured":"Pennell PB, Peng L, Newport DJ et\u00a0al (2008) Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency. Neurology 70:2130\u20132136","journal-title":"Neurology"},{"key":"210_CR35","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.eplepsyres.2009.02.011","volume":"85","author":"C Fotopoulou","year":"2009","unstructured":"Fotopoulou C, Kretz R, Bauer S et al (2009) Prospectively assessed changes in lamotrigine-concentration in women with epilepsy during pregnancy, lactation and the neonatal period. Epilepsy Res 85:60\u201364","journal-title":"Epilepsy Res"},{"key":"210_CR36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.yebeh.2013.06.026","volume":"29","author":"TL Reisinger","year":"2013","unstructured":"Reisinger TL, Newman M, Loring DW et\u00a0al (2013) Antiepileptic drug clearance and seizure frequency during pregnancy in women with epilepsy. Epilepsy Behav 29:13\u201318","journal-title":"Epilepsy Behav"},{"key":"210_CR37","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/WCO.0b013e32832923d7","volume":"22","author":"A Sabers","year":"2009","unstructured":"Sabers A, Tomson T (2009) Managing antiepileptic drugs during pregnancy and lactation. Curr Opin Neurol 22:157\u2013161","journal-title":"Curr Opin Neurol"},{"key":"210_CR38","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1111\/j.1528-1167.2010.02771.x","volume":"51","author":"I Wegner","year":"2010","unstructured":"Wegner I, Edelbroek P, De Haan GJ et\u00a0al (2010) Drug monitoring of lamotrigine and oxcarbazepine combination during pregnancy. Epilepsia 51:2500\u20132502","journal-title":"Epilepsia"},{"key":"210_CR39","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/j.1600-0404.2011.01627.x","volume":"126","author":"A Sabers","year":"2012","unstructured":"Sabers A (2012) Algorithm for lamotrigine dose adjustment before, during, and after pregnancy. Acta Neurol Scand 126:e1\u2013e4","journal-title":"Acta Neurol Scand"},{"key":"210_CR40","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.seizure.2015.02.018","volume":"28","author":"I Borthen","year":"2015","unstructured":"Borthen I (2015) Obstetrical complications in women with epilepsy. Seizure 28:32\u201334","journal-title":"Seizure"},{"key":"210_CR41","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1001\/jamaneurol.2015.1017","volume":"72","author":"SC Macdonald","year":"2015","unstructured":"Macdonald SC, Bateman BT, Mcelrath TF et\u00a0al (2015) Mortality and morbidity during delivery hospitalization among pregnant women with epilepsy in the united states. JAMA Neurol 72:981\u2013988","journal-title":"JAMA Neurol"},{"key":"210_CR42","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/S0140-6736(15)00045-8","volume":"386","author":"L Viale","year":"2015","unstructured":"Viale L, Allotey J, Cheong-See F et al (2015) Epilepsy in pregnancy and reproductive outcomes: a systematic review and meta-analysis. Lancet 386:1845\u20131852","journal-title":"Lancet"},{"key":"210_CR43","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/jamapediatrics.2014.118","volume":"168","author":"KJ Meador","year":"2014","unstructured":"Meador KJ, Baker GA, Browning N et\u00a0al (2014) Breastfeeding in children of women taking antiepileptic drugs: cognitive outcomes at age 6 years. JAMA Pediatr 168:729\u2013736","journal-title":"JAMA Pediatr"},{"key":"210_CR44","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.seizure.2015.02.013","volume":"28","author":"G Veiby","year":"2015","unstructured":"Veiby G, Bjork M, Engelsen BA et\u00a0al (2015) Epilepsy and recommendations for breastfeeding. Seizure 28:57\u201365","journal-title":"Seizure"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-016-0210-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-016-0210-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-016-0210-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T15:17:53Z","timestamp":1657293473000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-016-0210-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,15]]},"references-count":44,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["210"],"URL":"https:\/\/doi.org\/10.1007\/s00115-016-0210-1","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,15]]}}}